Medicine & Life Sciences
Tumor Burden
100%
Pandemics
95%
Circulating Tumor DNA
64%
Clinical Trials
58%
Response Evaluation Criteria in Solid Tumors
57%
Mutation
56%
Coronavirus
56%
Immunotherapy
52%
Neoplasms
50%
Microsatellite Repeats
47%
High-Throughput Nucleotide Sequencing
43%
Survival
40%
Hepatocellular Carcinoma
36%
Patient Care
34%
Health Care Quality Indicators
34%
Biomarkers
33%
Cross-Sectional Studies
31%
Severe Acute Respiratory Syndrome
29%
Guideline Adherence
28%
Urbanization
28%
Authorship
27%
Non-Small Cell Lung Carcinoma
26%
Safety
26%
Telemedicine
24%
Public Policy
24%
Poverty
24%
Gastrointestinal Diseases
23%
Health Policy
22%
Therapeutics
21%
Pharmaceutical Preparations
18%
Population
17%
Linear Models
17%
Clinical Trials Data Monitoring Committees
17%
Communication
16%
Direction compound
16%
Occupational Groups
16%
Public Health
16%
Healthcare Disparities
15%
Regression Analysis
14%
Survivors
13%
North America
12%
Lung Neoplasms
11%
Survival Rate
11%
Random Allocation
11%
Interdisciplinary Research
10%
Empirical Research
9%
Programmed Cell Death 1 Receptor
9%
Health Care Outcome Assessment
9%
Growth
9%
Social Sciences
self-organization
54%
efficiency
31%
trend
22%
biomedical research
20%
gatekeeper
12%
funding
12%
time
12%
health
10%
travel
10%
editor
9%
transparency
9%
Clinical Trials
9%
market economy
9%
scientific community
9%
interaction
8%
medicine
8%
staging
7%
resources
7%
incidence
7%
mortality
7%
hospitalization
7%
human being
6%
savings
6%
autonomy
6%
telephone
5%
political attitude
5%
cross-sectional study
5%
health policy
5%
organization
5%
urbanization
5%
university
5%
performance
5%
illness
5%